7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol and Granulocytic Leukemia, Chronic

7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol has been researched along with Granulocytic Leukemia, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Birtwistle, J; Bunce, CM; Chipman, JK; Davies, NJ; Green, RM; Hayden, RE; Khanim, FL; Pearce, C; Ride, JP; Schrewe, H; Wake, N	1

Other Studies

1 other study(ies) available for 7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol and Granulocytic Leukemia, Chronic

Article	Year
The aldo-keto reductase AKR1C3 contributes to 7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol mediated oxidative DNA damage in myeloid cells: implications for leukemogenesis. Mutation research, 2009, Mar-09, Volume: 662, Issue:1-2 Topics: 3-Hydroxysteroid Dehydrogenases; 9,10-Dimethyl-1,2-benzanthracene; Aldo-Keto Reductase Family 1 Member C3; Cell Differentiation; Cell Line, Tumor; DNA Damage; Gene Expression Regulation, Leukemic; Gene Knockdown Techniques; Glycophorins; Hemoglobins; Humans; Hydroxyprostaglandin Dehydrogenases; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Oxidative Stress; Stem Cells	2009

Article

Year

The aldo-keto reductase AKR1C3 contributes to 7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol mediated oxidative DNA damage in myeloid cells: implications for leukemogenesis.

Mutation research, 2009, Mar-09, Volume: 662, Issue:1-2

Topics: 3-Hydroxysteroid Dehydrogenases; 9,10-Dimethyl-1,2-benzanthracene; Aldo-Keto Reductase Family 1 Member C3; Cell Differentiation; Cell Line, Tumor; DNA Damage; Gene Expression Regulation, Leukemic; Gene Knockdown Techniques; Glycophorins; Hemoglobins; Humans; Hydroxyprostaglandin Dehydrogenases; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Oxidative Stress; Stem Cells

2009